Genomic Prediction is behind LifeViewTM, an embryo screening test that offers advanced testing for embryo health resulting in higher pregnancy and birth rates. Genomic Prediction’s mission is to improve the success rate of IVF by offering patients the most comprehensive genetic analysis of the preimplantation embryo available today. The test includes routine screening to check for chromosome number and of biological parents to check genes associated with increased miscarriage risk. Patients who use LifeView are also given access to an Embryo Health Scores that uses a combination of genetic variants to calculate the chances of conditions like diabetes and cancer. Genomic Prediction is highly recommended by clinicians, now operating in 37 countries.

Genomic Prediction

Founded: 2017
Location: North Brunswick, NJ
Employee range: 11 - 50
Funding: $4.5M Jan 2019

Short description:

Drug notes:

Long description:

Jobs: